Earnings call transcript: QFIN Holdings Q4 2025 earnings miss expectations

QFIN reported Q4 2025 EPS of 7.82 (vs. 9.17 expected, -14.72% surprise) and revenue of CNY 4.09bn (vs. CNY 5.03bn expected, -18.69% surprise), with non-GAAP net income down to CNY 1.07bn (-45.7% YoY). Loan origination volume fell 21.8% YoY to CNY 70.3bn while Technology Solutions loan volume surged ~448% YoY and outstanding balance approached CNY 11.7bn. Management flagged regulatory-driven liquidity pressure, guided FY2026 EPS and revenue below FY2025, and maintained large capital returns in 2025 (~$200m dividends and ~$680m buybacks) while repurchasing convertible bonds to strengthen the balance sheet. Risk metrics are showing early improvement (C-M2 0.97% in Q4, CM2 down 8.2% MoM in Jan) but near-term outlook remains cautious.

Analysis

QFIN’s pivot from a pure consumer-finance marketplace toward an AI-driven Technology Solutions provider is the strategic lever that changes the game: it converts transactional platform revenue (sensitive to regulatory take‑rate compression) into recurring, institutionally underwritten loan flows that are easier to warehouse, securitize, and cross‑sell. That shift reduces marginal regulatory beta per dollar of assets but raises execution and model‑transfer risk as management scales models across jurisdictions with different credit data regimes.

Near‑term performance is being propped up by two transient effects that can reverse: (1) PBOC remediation and collection policy timing that temporarily boosts cure rates and collection metrics, and (2) active balance‑sheet engineering (repurchases of convertibles and shares) that mechanically inflates EPS and reduces float. Both create a smoother path for the stock in the coming quarters but mask underlying funding and origination fragility that could reappear as liquidity tightness persists.

The most important second‑order winner is AI/infra vendors and enterprise software partners (the middleware that enables banks to adopt “Focus Pro”); their order books should get a tailwind as banks outsource risk models and operations. Conversely, marginal high‑yield micro‑lenders and ABS buyers lacking diversified origination channels are exposed — spread re‑pricing in ABS markets would hit them first and fastest.

Timing: expect the market to re-rate on two catalysts — ABS issuance cadence and cross‑border pilot scale in 3–12 months. Monitor early overseas vintages and ABS pricing as leading indicators; a sustained tightening in ABS spreads or a reversal in post‑remediation cure rates are 30–120 day negative catalysts that would materially compress implied valuations.

Key Decisions for Investors

• Small tactical long in QFIN (size 2–4% of risk budget) with explicit hedge: buy QFIN equity and purchase a 6–12 month put ~25% out‑of‑the‑money to cap downside. Time horizon 6–12 months; upside if Technology Solutions adoption and ABS access normalize; downside limited to ~25% by hedge, tail risk remains if regulation tightens further.
• Buy SMCI (AI infra exposure) via a 9–12 month call spread (buy near‑the‑money call, sell 30–40% OTM call) to capture AI spending tailwinds from fintechs and banks adopting on‑prem inference. Cost‑effective way to express durable demand for servers; risk is chip/contention slowing capex and 2:1 reward:cost if secular demand persists.
• Event pair: long QFIN / short a small, domestically focused consumer‑credit name (replaceable with a watchlist candidate) sized 1:1 to express conviction in QFIN’s institutional pivot. This isolates regulatory/systemic funding moves — if ABS markets tighten, the short should outperform; if international pilots succeed, the long leverages re‑rating.
• Avoid outright leverage on QFIN until ABS strip pricing stabilizes; set an alert to trim longs if ABS spreads widen by >100bps or if monthly cure rates retreat for two consecutive months — these are 30–90 day stop triggers that preserve capital against regulatory surprise.